Jefferies Reiterates Hold on Abbott Laboratories, Maintains $120 Price Target
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Raj Denhoy has reiterated a Hold rating on Abbott Laboratories, maintaining a price target of $120.
September 26, 2024 | 5:41 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Jefferies analyst Raj Denhoy has reiterated a Hold rating on Abbott Laboratories, maintaining a price target of $120.
The reiteration of a Hold rating and maintenance of the $120 price target by Jefferies suggests a neutral outlook for Abbott Laboratories in the short term. This indicates that the analyst does not foresee significant changes in the stock's performance, aligning with the current market valuation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100